Adenylate Kinase: A Ubiquitous Enzyme Correlated with Medical Conditions

  • Mihaela Ileana IonescuEmail author


Adenylate kinase is a small, usually monomeric, enzyme found in every living thing due to its crucial role in energetic metabolism. This paper outlines the most relevant data about adenylate kinases isoforms, and the connection between dysregulation or mutation of human adenylate kinase and medical conditions. The following datadases were consulted: National Centre for Biotechnology Information, Protein Data Bank, and Mouse Genomic Informatics. The SmartBLAST tool, EMBOSS Needle Program, and Clustal Omega Program were used to analyze the best protein match, and to perform pairwise sequence alignment and multiple sequence alignment. Human adenylate kinase genes are located on different chromosomes, six of them being on the chromosomes 1 and 9. The adenylate kinases’ intracellular localization and organ distribution explain their dysregulation in many diseases. The cytosolic isoenzyme 1 and the mitochondrial isoenzyme 2 are the main adenylate kinases that are integrated in the vast network of inflammatory modulators. The cytosolic isoenzyme 5 is correlated with limbic encephalitis and Leu673Pro mutation of the isoenzyme 7 leads to primary male infertility due to impairment of the ciliary function. The impairment of the mitochondrial isoenzymes 2 and 4 is demonstrated in neuroblastoma or glioma. The adenylate kinases are disease modifier that can assess the risk of diseases where oxidative stress plays a crucial role in pathogenesis like metabolic syndrome or neurodegenerative diseases. Because adenylate kinases has ATP as substrate, they are integrated in the global network of energetic process of any organism therefore are valid target for new pharmaceutical compounds.


Adenylate kinase Nucleotide metabolism Phosphotransfer enzymes AMP-activated protein kinase Adenine nucleotide Homeostasis 



Adenosine diphosphate


Adenylate kinase


Adenosine monophosphate


AMP-activated protein kinases




Adenosine triphosphate




Basic local alignment search tool


BLOcks SUbstitution Matrix


Cytidine diphosphate


Deoxy-nucleoside triphosphates


Aspartic acid glycine tyrosine proline


Guanosine triphosphate


Human coilin interacting nuclear ATPase protein


Mouse genomic informatics


Multiple morphological abnormalities of the sperm flagella


National Centre for Biotechnology Information


Nucleoside triphosphates


Phosphate-binding loop


Primary ciliary dyskinesia


PROTEIN data bank


Protein kinase c-AMP activated catalytic subunit beta


RNA-mediated interference




Serine glycine lysine

UMP-CMP kinase

Uridine monophosphate-cytidine monophosphate kinase



This work is dedicated to the memory of Professor Dr. Octavian Bârzu, my mentor in the study of nucleoside monophosphate kinases. This work was supported by a grant of Ministery of Research and Innovation, CNCS - UEFISCDI, project number PN-III-P4-ID-PCCF-2016-0016, within PNCDI III. The author would like to thank the referees for their generous and useful comments that have greatly improved the manuscript.

Compliance with Ethical Standards

Conflict of interest

The authors declare that she has no conflicts of interest.


  1. 1.
    Lanning NJ, Looyenga BD, Kauffman AL, Niemi NM, Sudderth J, DeBerardinis RJ, MacKeigan JP (2014) A mitochondrial RNAi screen defines cellular bioenergetic determinants and identifies an adenylate kinase as a key regulator of ATP levels. Cell Rep 7:907–917. CrossRefGoogle Scholar
  2. 2.
    Berry MB, Meador B, Bilderback T, Liang P, Glaser M, Phillips GN (1994) The closed conformation of a highly flexible protein: the structure of E. coli adenylate kinase with bound AMP and AMPPNP. Proteins Struct Funct Bioinform 19:183–198. CrossRefGoogle Scholar
  3. 3.
    Rogne P, Rosselin M, Grundström C, Hedberg C, Sauer UH, Wolf-Watz M (2018) Molecular mechanism of ATP versus GTP selectivity of adenylate kinase. Proc Natl Acad Sci USA. Google Scholar
  4. 4.
    Kuby SA, Hamada M, Johnson MS, Russell GA, Manship M, Palmieri RH, Fleming G, Bredt DS, Mildvan AS (1989) Studies on adenosine triphosphate transphosphorylases. XVIII. Synthesis and preparation of peptides and peptide fragments of rabbit muscle ATP-AMP transphosphorylase (adenylate kinase) and their nucleotide-binding properties. J Protein Chem 8:549–562. CrossRefGoogle Scholar
  5. 5.
    Rundqvist L, Aden J, Sparrman T, Wallgren M, Olsson U, Wolf-Watz M (2009) Noncooperative folding of subdomains in adenylate kinase. Biochemistry 48:1911–1927. CrossRefGoogle Scholar
  6. 6.
    Wang Y, Makowski L (2018) Fine structure of conformational ensembles in adenylate kinase. Proteins 86:332–343. CrossRefGoogle Scholar
  7. 7.
    Noma T (2005) Dynamics of nucleotide metabolism as a supporter of life phenomena. J Med Invest 52:127–136. CrossRefGoogle Scholar
  8. 8.
    Dzeja P, Terzic A (2009) Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing. Int J Mol Sci 10:1729–1772. CrossRefGoogle Scholar
  9. 9.
    Fujisawa K, Terai S, Takami T, Yamamoto N, Yamasaki T, Matsumoto T, Yamaguchi K, Owada Y, Nishina H, Noma T, Sakaida I (2016) Modulation of anti-cancer drug sensitivity through the regulation of mitochondrial activity by adenylate kinase 4. J Exp Clin Cancer Res 35:48. CrossRefGoogle Scholar
  10. 10.
    Formoso E, Limongelli V, Parrinello M (2015) Energetics and structural characterization of the large-scale functional motion of adenylate kinase. Sci Rep 5:8425CrossRefGoogle Scholar
  11. 11.
    Lin CY, Huang JY, Lo L-W (2013) Deciphering the catalysis-associated conformational changes of human adenylate kinase 1 with single-molecule spectroscopy. J Phys Chem B 117:13947–13955. CrossRefGoogle Scholar
  12. 12.
    Müller CW, Schlauderer GJ, Reinstein J, Schulz GE (1996) Adenylate kinase motions during catalysis: an energetic counterweight balancing substrate binding. Structure 4:147–156. CrossRefGoogle Scholar
  13. 13.
    Muller CW, Schulz GE (1988) Structure of the complex of adenylate kinase from Escherichia coli with the inhibitor P1,P5-di(adenosine-5′-)pentaphosphate. J Mol Biol 202:909–912CrossRefGoogle Scholar
  14. 14.
    Muller CW, Schulz GE (1992) Structure of the complex between adenylate kinase from Escherichia coli and the inhibitor Ap5A refined at 1.9 A resolution. A model for a catalytic transition state. J Mol Biol 224:159–177CrossRefGoogle Scholar
  15. 15.
    Fukami-Kobayashi K, Nosaka M, Nakazawa A, Go M (1996) Ancient divergence of long and short isoforms of adenylate kinase: molecular evolution of the nucleoside monophosphate kinase family. FEBS Lett 385:214–220. CrossRefGoogle Scholar
  16. 16.
    Wujak M, Czarnecka J, Gorczycka M, Hetmann A (2015) Human adenylate kinases—classification, structure, physiological and pathological importance. Postepy Hig Med Dosw (Online) 69:933–945. CrossRefGoogle Scholar
  17. 17.
    Dzeja PP, Zeleznikar RJ, Goldberg ND (1998) Adenylate kinase: kinetic behavior in intact cells indicates it is integral to multiple cellular processes. Mol Cell Biochem 184:169–182CrossRefGoogle Scholar
  18. 18.
    Rice P, Longden I, Bleasby A (2000) EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 16:276–277CrossRefGoogle Scholar
  19. 19.
    Ravera S, Calzia D, Panfoli I, Pepe IM, Morelli A (2007) Simultaneous detection of molecular weight and activity of adenylate kinases after electrophoretic separation. Electrophoresis 28:291–300. CrossRefGoogle Scholar
  20. 20.
    Haft DH, Loftus BJ, Richardson DL, Yang F, Eisen JA, Paulsen IT, White O (2001) TIGRFAMs: a protein family resource for the functional identification of proteins. Nucleic Acids Res 29:41–43CrossRefGoogle Scholar
  21. 21.
    Panayiotou C, Solaroli N, Karlsson A (2014) The many isoforms of human adenylate kinases. Int J Biochem Cell Biol 49:75–83. CrossRefGoogle Scholar
  22. 22.
    Panayiotou C, Solaroli N, Xu Y, Johansson M, Karlsson A (2011) The characterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes. Biochem J 433:527–534. CrossRefGoogle Scholar
  23. 23.
    Lonergan KM, Chari R, DeLeeuw RJ, Shadeo A, Chi B, Tsao MS, Jones S, Marra M, Ling V, Ng R, MacAulay C, Lam S, Lam WL (2006) Identification of novel lung genes in bronchial epithelium by serial analysis of gene expression. Am J Respir Cell Mol Biol 35:651–661. CrossRefGoogle Scholar
  24. 24.
    Lee Y, Kim JW, Lee IA, Kang HB, Choe YK, Lee HG, Lim JS, Kim HJ, Park C, Choe IS (1996) Cloning and characterization of cDNA for human adenylate kinase 2A. Biochem Mol Biol Int 39:833–842Google Scholar
  25. 25.
    Lee Y, Kim JW, Lee SM, Kim HJ, Lee KS, Park C, Choe IS (1998) Cloning and expression of human adenylate kinase 2 isozymes: differential expression of adenylate kinase 1 and 2 in human muscle tissues. J Biochem 123:47–54CrossRefGoogle Scholar
  26. 26.
    Sorrentino V, Menzies KJ, Auwerx J (2018) Repairing mitochondrial dysfunction in disease. Annu Rev Pharmacol Toxicol. Google Scholar
  27. 27.
    Liu R, Xu H, Wei Z, Wang Y, Lin Y, Gong W (2008) Crystal structure of human adenylate kinase 4 (L171P) suggests the role of hinge region in protein domain motion. Biochem Biophys Res Commun 379:92–97. CrossRefGoogle Scholar
  28. 28.
    Ren H, Wang L, Bennett M, Liang Y, Zheng X, Lu F, Li L, Nan J, Luo M, Eriksson S, Zhang C, Su X-D (2005) The crystal structure of human adenylate kinase 6: an adenylate kinase localized to the cell nucleus. Proc Natl Acad Sci USA 102:303–308. CrossRefGoogle Scholar
  29. 29.
    Drakou CE, Malekkou A, Hayes JM, Lederer CW, Leonidas DD, Oikonomakos NG, Lamond AI, Santama N, Zographos SE (2012) hCINAP is an atypical mammalian nuclear adenylate kinase with an ATPase motif: structural and functional studies. Proteins 80:206–220. CrossRefGoogle Scholar
  30. 30.
    Amiri M, Conserva F, Panayiotou C, Karlsson A, Solaroli N (2013) The human adenylate kinase 9 is a nucleoside mono- and diphosphate kinase. Int J Biochem Cell Biol 45:925–931. CrossRefGoogle Scholar
  31. 31.
    (2018) Focusing on mitochondrial form and function. Nat Cell Biol.,
  32. 32.
    Gloria-Bottini F, Neri A, Pietropolli A, Bottini E, Magrini A (2013) Ak 1 genetic polymorphism and season of conception. Eur J Obstet Gynecol Home. Google Scholar
  33. 33.
    Hewitson JP, Grainger JR, Maizels RM (2009) Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol 167:1–11. CrossRefGoogle Scholar
  34. 34.
    McSorley HJ, Hewitson JP, Maizels RM (2013) Immunomodulation by helminth parasites: defining mechanisms and mediators. Int J Parasitol 43:301–310. CrossRefGoogle Scholar
  35. 35.
    Gao Y, Zhou X, Wang H, Liu R, Ye Q, Zhao Q, Ming Z, Dong H (2017) Immunization with recombinant schistosome adenylate kinase 1 partially protects mice against Schistosoma japonicum infection. Parasitol Res 116:1665–1674. CrossRefGoogle Scholar
  36. 36.
    Cao Z, Huang Y, Wang T (2017) Schistosomiasis japonica control in domestic animals: progress and experiences in China. Front Microbiol 8:2464. CrossRefGoogle Scholar
  37. 37.
    Loukovaara S, Sandholm J, Aalto K, Liukkonen J, Jalkanen S, Yegutkin GG (2017) Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy. J Mol Med 95:193–204. CrossRefGoogle Scholar
  38. 38.
    Notomi S, Hisatomi T, Murakami Y, Terasaki H, Sonoda S, Asato R, Takeda A, Ikeda Y, Enaida H, Sakamoto T, Ishibashi T (2013) Dynamic increase in extracellular ATP accelerates photoreceptor cell apoptosis via ligation of P2RX7 in subretinal hemorrhage. PLoS ONE. Google Scholar
  39. 39.
    Zhong Y, Yang Z, Huang WC, Luo X (2013) Adenosine, adenosine receptors and glaucoma: an updated overview. Biochim Biophys Acta 1830:2882–2890. CrossRefGoogle Scholar
  40. 40.
    Sanderson J, Dartt DA, Trinkaus-Randall V, Pintor J, Civan MM, Delamere NA, Fletcher EL, Salt TE, Grosche A, Mitchell CH (2014) Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Müller cells, lens, trabecular meshwork, cornea and lacrimal gland. Exp Eye Res 127:270–279. CrossRefGoogle Scholar
  41. 41.
    Ito K, Suda T (2014) Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol 15:243–256. CrossRefGoogle Scholar
  42. 42.
    Burkart A, Shi X, Chouinard M, Corvera S (2011) Adenylate kinase 2 links mitochondrial energy metabolism to the induction of the unfolded protein response. J Biol Chem 286:4081–4089. CrossRefGoogle Scholar
  43. 43.
    Pannicke U, Hönig M, Hess I, Friesen C, Holzmann K, Rump EM, Barth TF, Rojewski MT, Schulz A, Boehm T, Friedrich W, Schwarz K (2009) Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet 41:101–105. CrossRefGoogle Scholar
  44. 44.
    Klein C (2009) Congenital neutropenia. Hematology 2009:344–350. CrossRefGoogle Scholar
  45. 45.
    Six E, Lagresle-Peyrou C, Susini S, De Chappedelaine C, Sigrist N, Sadek H, Chouteau M, Cagnard N, Fontenay M, Hermine O, Chomienne C, Reynier P, Fischer A, André-Schmutz I, Gueguen N, Cavazzana M (2015) AK2 deficiency compromises the mitochondrial energy metabolism required for differentiation of human neutrophil and lymphoid lineages. Cell Death Dis 6:e1856. CrossRefGoogle Scholar
  46. 46.
    Chandel NS (2014) Mitochondria as signaling organelles. BMC Biol 12:34. CrossRefGoogle Scholar
  47. 47.
    Meyer A, Laverny G, Bernardi L, Charles AL, Alsaleh G, Pottecher J, Sibilia J, Geny B (2018) Mitochondria: an organelle of bacterial origin controlling inflammation. Front Immunol 9:1–8. CrossRefGoogle Scholar
  48. 48.
    Tüzün E, Rossi JE, Karner SF, Centurion AF, Dalmau J (2007) Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis. J Neuroimmunol 186:177–180. CrossRefGoogle Scholar
  49. 49.
    Do L-D, Chanson E, Desestret V, Joubert B, Ducray F, Brugière S, Couté Y, Formaglio M, Rogemond V, Thomas-Antérion C, Borrega L, Laurens B, Tison F, Curot J, De Brouker T, Lebrun-Frenay C, Delattre J-Y, Antoine J-C, Honnorat J (2017) Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies. Neurology 88:514–524. CrossRefGoogle Scholar
  50. 50.
    Ng ASL, Kramer J, Centurion A, Dalmau J, Huang E, Cotter JA, Geschwind MD (2015) Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis. J Neuroimmunol 287:31–35. CrossRefGoogle Scholar
  51. 51.
    Zhai R, Meng G, Zhao Y, Liu B, Zhang G, Zheng X (2006) A novel nuclear-localized protein with special adenylate kinase properties from Caenorhabditis elegans.
  52. 52.
    Feng X, Yang R, Zheng X, Zhang F (2012) Identification of a novel nuclear-localized adenylate kinase 6 from Arabidopsis thaliana as an essential stem growth factor. Plant Physiol Biochem 61:180–186. CrossRefGoogle Scholar
  53. 53.
    Van Horssen R, Janssen E, Peters W, Van de Pasch L, Te Lindert MM, Van Dommelen MMT, Linssen PC, Ten Hagen TLM, Fransen JAM, Wieringa B (2009) Modulation of cell motility by spatial repositioning of enzymatic ATP/ADP exchange capacity. J Biol Chem 284:1620–1627. CrossRefGoogle Scholar
  54. 54.
    Lorès P, Coutton C, El Khouri E, Stouvenel L, Givelet M, Thomas L, Rode B, Schmitt A, Louis B, Sakheli Z, Chaudhry M, Fernandez-Gonzales A, Mitsialis A, Dacheux D, Wolf JP, Papon JF, Gacon G, Escudier E, Arnoult C, Bonhivers M, Savinov SN, Amselem S, Ray PF, Dulioust E, Touré A (2018) Homozygous missense mutation L673P in adenylate kinase 7 (AK7) leads to primary male infertility and multiple morphological anomalies of the flagella but not to primary ciliary dyskinesia. Hum Mol Genet 27:1196–1211. CrossRefGoogle Scholar
  55. 55.
    Afzelius BA, Eliasson R (1979) Flagellar mutants in man: on the heterogeneity of the immotile-cilia syndrome. J Ultrastruct Res 69:43–52CrossRefGoogle Scholar
  56. 56.
    Afzelius BA (1976) A human syndrome caused by immotile cilia. Science 193:317–319CrossRefGoogle Scholar
  57. 57.
    Lucas JS, Barbato A, Collins SA, Goutaki M, Behan L, Caudri D, Dell S, Eber E, Escudier E, Hirst RA, Hogg C, Jorissen M, Latzin P, Legendre M, Leigh MW, Midulla F, Nielsen KG, Omran H, Papon JF, Pohunek P, Redfern B, Rigau D, Rindlisbacher B, Santamaria F, Shoemark A, Snijders D, Tonia T, Titieni A, Walker WT, Werner C, Bush A, Kuehni CE (2017) European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J. Google Scholar
  58. 58.
    Fernandez-Gonzalez A, Kourembanas S, Wyatt TA, Mitsialis SA (2009) Mutation of murine adenylate kinase 7 underlies a primary ciliary dyskinesia phenotype. Am J Respir Cell Mol Biol 40:305–313. CrossRefGoogle Scholar
  59. 59.
    Seccia TM, Atlante A, Vulpis V, Marra E, Passarella S, Pirrelli A (1998) Mitochondrial energy metabolism in the left ventricular tissue of spontaneously hypertensive rats: abnormalities in both adeninenucleotide and phosphate translocators and enzyme adenylate-kinase and creatine-phosphokinase activities. Clin Exp Hypertens 20:345–358CrossRefGoogle Scholar
  60. 60.
    Wang ZH, Cai XL, Wu L, Yu Z, Liu JL, Zhou ZN, Liu J, Yang HT (2012) Mitochondrial energy metabolism plays a critical role in the cardioprotection afforded by intermittent hypobaric hypoxia. Exp Physiol 97:1105–1118. CrossRefGoogle Scholar
  61. 61.
    Ge Y, Molloy MP, Chamberlain JS, Andrews PC (2003) Proteomic analysis of mdx skeletal muscle: great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 3:1895–1903. CrossRefGoogle Scholar
  62. 62.
    Myers RW, Guan H-P, Ehrhart J, Petrov A, Prahalada S, Tozzo E, Yang X, Kurtz MM, Trujillo M, Gonzalez Trotter D, Feng D, Xu S, Eiermann G, Holahan MA, Rubins D, Conarello S, Niu X, Souza SC, Miller C, Liu J, Lu K, Feng W, Li Y, Painter RE, Milligan JA, He H, Liu F, Ogawa A, Wisniewski D, Rohm RJ, Wang L, Bunzel M, Qian Y, Zhu W, Wang H, Bennet B, LaFranco Scheuch L, Fernandez GE, Li C, Klimas M, Zhou G, van Heek M, Biftu T, Weber A, Kelley DE, Thornberry N, Erion MD, Kemp DM, Sebhat IK (2017) Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy. Science 357:507–511. CrossRefGoogle Scholar
  63. 63.
    Kodiha M, Stochaj U (2011) AMP kinase: the missing link between type 2 diabetes and neurodegenerative diseases? Trends Mol Med 17:613–614. CrossRefGoogle Scholar
  64. 64.
    Kang S, Lee YH, Lee JE (2017) Metabolism-centric overview of the pathogenesis of Alzheimer’s Disease. Yonsei Med J 58:479–488. CrossRefGoogle Scholar
  65. 65.
    Baldassarre MPA, Andersen A, Consoli A, Knop FK, Vilsbøll T (2018) Cardiovascular biomarkers in clinical studies of type 2 diabetes. Diabetes Obes Metab. Google Scholar
  66. 66.
    Miller E, Morel A, Saso L, Saluk J (2014) Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases. Oxid Med Cell Longev. Google Scholar
  67. 67.
    Garcia-Esparcia P, Hernández-Ortega K, Ansoleaga B, Carmona M, Ferrer I (2015) Purine metabolism gene deregulation in Parkinson’s disease. Neuropathol Appl Neurobiol 41:926–940. CrossRefGoogle Scholar
  68. 68.
    WARBURG O (1956) On respiratory impairment in cancer cells. Science 124:269–270Google Scholar
  69. 69.
    de Padua MC, Delodi G, Vučetić M, Durivault J, Vial V, Bayer P, Rodrigues Noleto G, Mazure NM, Ždralević M, Pouysségur J (2017) Disrupting glucose-6-phosphate isomerase fully suppresses the “Warburg effect” and activates OXPHOS with minimal impact on tumor growth except in hypoxia. Oncotarget 8:87623–87637. CrossRefGoogle Scholar
  70. 70.
    Ounpuu L, Klepinin A, Pook M, Teino I, Peet N, Paju K, Tepp K, Chekulayev V, Shevchuk I, Koks S, Maimets T, Kaambre T (2017) 2102Ep embryonal carcinoma cells have compromised respiration and shifted bioenergetic profile distinct from H9 human embryonic stem cells. Biochim Biophys Acta 1861:2146–2154. CrossRefGoogle Scholar
  71. 71.
    Klepinin A, Chekulayev V, Timohhina N, Shevchuk I, Tepp K, Kaldma A, Koit A, Saks V, Kaambre T (2014) Comparative analysis of some aspects of mitochondrial metabolism in differentiated and undifferentiated neuroblastoma cells. J Bioenerg Biomembr 46:17–31. CrossRefGoogle Scholar
  72. 72.
    Liu R, Ström A-L, Zhai J, Gal J, Bao S, Gong W, Zhu H, Strom A-L, Zhai J, Gal J, Bao S, Gong W, Zhu H (2009) Enzymatically inactive adenylate kinase 4 interacts with mitochondrial ADP/ATP translocase. Int J Biochem Cell Biol 41:1371–1380. CrossRefGoogle Scholar
  73. 73.
    Matsuura S, Igarashi M, Tanizawa Y, Yamada M, Kishi F, Kajii T, Fujii H, Miwa S, Sakurai M, Nakazawa A (1989) Human adenylate kinase deficiency associated with hemolytic anemia. A single base substitution affecting solubility and catalytic activity of the cytosolic adenylate kinase. J Biol Chem 264:10148–10155Google Scholar
  74. 74.
    Corrons J-LV, Garcia E, Tusell JJ, Varughese KI, West C, Beutler E (2003) Red cell adenylate kinase deficiency: molecular study of 3 new mutations (118G>A, 190G>A,and GAC deletion) associated with hereditary nonspherocytic hemolytic anemia. Blood 102:353–356. CrossRefGoogle Scholar
  75. 75.
    Shin Y, Brangwynne CP (2017) Liquid phase condensation in cell physiology and disease. Science 357:eaaf4382. CrossRefGoogle Scholar
  76. 76.
    Lam C-W, Wong K-S, Leung H-W, Law C-Y (2017) Limb girdle myasthenia with digenic RAPSN and a novel disease gene AK9 mutations. Eur J Hum Genet 25:192–199. CrossRefGoogle Scholar
  77. 77.
    Rodriguez Cruz PM, Palace J, Beeson D (2014) Congenital myasthenic syndromes and the neuromuscular junction. Curr Opin Neurol 27:566–575. CrossRefGoogle Scholar
  78. 78.
    Urasaki Y, Pizzorno G, Le TT (2014) Uridine affects liver protein glycosylation, insulin signaling, and heme biosynthesis. PLoS ONE 9:e99728. CrossRefGoogle Scholar
  79. 79.
    Hye Ji E, Cui L, Yuan X, Cheng S, Messadi D, Yan X, Hu S, Yan X (2017) Metabolomic analysis of human oral cancer cells with adenylate kinase 2 or phosphorylate glycerol kinase 1 inhibition. J Cancer. Google Scholar
  80. 80.
    Xiao Y, Sha W, Tian Z, Chen Y, Ji P, Sun Q, Wang H, Wang S, Fang Y, Wen H-L, Zhao H, Lu J, Xiao H, Fan X, Shen H, Wang Y (2016) Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis. J Mol Med 94:823–834. CrossRefGoogle Scholar
  81. 81.
    Bakke M, Suzuki S (2018) Development of a novel hygiene monitoring system based on the detection of total adenylate (ATP + ADP + AMP). J Food Prot 81:729–737. CrossRefGoogle Scholar
  82. 82.
    Day EA, Ford RJ, Steinberg GR (2017) AMPK as a therapeutic target for treating metabolic diseases. Trends Endocrinol Metab 28:545–560. CrossRefGoogle Scholar
  83. 83.
    Carling D (2017) AMPK signalling in health and disease. Curr Opin Cell Biol 45:31–37. CrossRefGoogle Scholar
  84. 84.
    Egeblad-Welin L, Welin M, Wang L, Eriksson S (2007) Structural and functional investigations of Ureaplasma parvum UMP kinase—a potential antibacterial drug target. FEBS J 274:6403–6414. CrossRefGoogle Scholar
  85. 85.
    Ionescu MI, Oniga O (2018) Molecular docking evaluation of (E)-5-arylidene-2-thioxothiazolidin-4-one derivatives as selective bacterial adenylate kinase inhibitors. Molecules. Google Scholar
  86. 86.
    Sharma S, Rao A (2009) RNAi screening: tips and techniques. Nat Immunol 10:799–804. CrossRefGoogle Scholar
  87. 87.
    Jiang W-M, Zhang X-Y, Zhang Y-Z, Liu L, Lu H-Z (2014) A high throughput RNAi screen reveals determinants of HIV-1 activity in host kinases. Int J Clin Exp Pathol 7:2229–2237Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Microbiology, Faculty of MedicineIuliu Haţieganu University of Medicine and PharmacyCluj-NapocaRomania
  2. 2.County Emergency Clinical HospitalCluj-NapocaRomania

Personalised recommendations